Drawing for PURESTREAM

USPTO serial 76182443

PURESTREAM

Reviewed by CopyMark Law Group

Reg. 2770667Status 710
Filing date
Status date
Registration date
Oct 7, 2003
Examiner
MCMORROW, RONALD G
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PURESTREAM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Diane Donnelly

DIANE DONNELLY VON MALTITZ, DERENBERG, KUNIN, ET AL60 E 42ND ST RM 4410NEW YORK, NY 10165UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001CHEMICAL AND BIOLOGICAL PREPARATIONS AND SUBSTANCE FOR IN-VITRO USE IN RESEARCH LABORATORIES, FOR SCIENTIFIC ANALYSIS, AND FOR INDUSTRIAL USE, NAMELY, FOR USE IN THE MANUFACTURE OF RNA AND RECOMBINANT PROTEINS; PLASMIDS FOR NUCLEIC ACID CLONING FOR SCIENTIFIC RESEARCH AND ANALYSIS, AND FOR INDUSTRIAL USE, NAMELY, FOR USE IN THE MANUFACTURE OF RNA AND RECOMBINANT PROTEINSSECTION 8 - CANCELLED—
005BIOACTIVE PEPTIDES AND PROTEINS FOR THERAPEUTIC USE; CHEMICAL AND BIOLOGICAL DIAGNOSTIC PREPARATIONS AND SUBSTANCES FOR CLINICAL OR MEDICAL LABORATORY USE; PLASMIDS FOR MANIPULATING DNA IN CELLS FOR MEDICAL THERAPEUTIC USE IN HUMANS OR ANIMALSSECTION 8 - CANCELLED—
040Manufacture of recombinant proteins to the specification of othersSECTION 8 - CANCELLED—
042Scientific and medical research and testing services; biological laboratory services, namely, synthesis and purification of recombinant proteins, target validation of therapeutic proteins and functional analysis of proteins; protein target profiling services; consulting and advisory services related theretoSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 15, 2010C8..CANCELLED SEC. 8 (6-YR)—
Feb 20, 2008CFITCASE FILE IN TICRS—
Oct 7, 2003R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 15, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 25, 2003NPUBNOTICE OF PUBLICATION—
Apr 29, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 14, 2003CNSIINQUIRY AS TO SUSPENSION MAILED—
Mar 6, 20031.BDSec. 1(B) CLAIM DELETED—
Mar 6, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 6, 2003MAILPAPER RECEIVED—
Jan 23, 2002CNSLLETTER OF SUSPENSION MAILED—
Oct 10, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 17, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 12, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance